文献速递肝病

非酒精性脂肪性肝病与非酒精性脂肪性肝炎的患者报告结局及经济影响:价值主张

Patient-Reported Outcomes and the Economic Effects of Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis: The Value Proposition.
PubMed 文献 · Hepatology · 2018-01-01

非酒精性脂肪性肝病(NAFLD)和非酒精性脂肪性肝炎(NASH)可进展为肝硬化、肝细胞癌(HCC)、死亡或肝移植,NASH还与健康相关生活质量受损相关并造成显著经济负担。本文从价值医疗视角综述NAFLD/NASH患者结局测量组成部分及其与经济负担的关系,旨在提供以患者为中心的优化诊疗。

要点

  • NAFLD和NASH可进展为肝硬化、肝细胞癌、死亡或肝移植。
  • NASH与健康相关生活质量受损相关,并造成显著经济负担。
  • 价值医疗中价值与临床及质量结局成正比、与实现这些结局的成本成反比。

核心结论

  • 有必要从价值医疗视角审视NAFLD,以提供以患者为中心的优化诊疗。

研究设计与样本

  • 综述,检索范围原文未报告。

主要发现

  • NAFLD和NASH可进展为肝硬化、肝细胞癌、死亡或肝移植。
  • NASH与健康相关生活质量受损相关,并造成显著经济负担。

关键数值与推荐

  • 价值医疗中价值与临床和质量结局成正比,与实现这些结局的成本成反比。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH) can progress to cirrhosis, hepatocellular carcinoma (HCC), death, or liver transplantation. NASH has also been associated with impaired health-related quality of life and poses a significant economic burden. Due to the negative clinical and patient-reported outcomes and economic burden of NAFLD, it is necessary to review this disease through the lens of value-based care, in which value is proportional to clinical and quality outcomes and inversely proportional to the costs of delivering these outcomes. I review the components of outcomes measured for patients with NAFLD and NASH and relate them to the value proposition, with the aim to deliver optimal patient-centered care.

来源:Hepatology,查看原文。版权归原作者所有。

引用

  1. Younossi ZM. Patient-Reported Outcomes and the Economic Effects of Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis: The Value Proposition. Hepatology. 2018. PMID: 30070714. doi:10.1002/hep.30125

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。